Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximilian Merz

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Nature Cancer|August 26, 2024
A comeback for checkpoint inhibition in multiple myelomaMaximilian Merz
Blood|September 25, 2025
Losing CD38 in myelomaMaximilian Merz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2024
Reply to Z. Yin et alNico Gagelmann, Maximilian Merz
Clinical Lymphoma, Myeloma & Leukemia|September 1, 2020
Bone Diseases and Supportive CareJens Hillengass, Maximilian Merz
Blood|January 9, 2025
GSI: myeloma-cold case closed?Maximilian Merz, Nico Gagelmann
Seminars in Hematology|August 2, 2024
Fast and furious: Changing gears on the road to cure with chimeric antigen receptor T cells in multiple myelomaNico Gagelmann, Maximilian Merz
Seminars in Hematology|May 16, 2018
Minimal residual disease in multiple myeloma: use of magnetic resonance imagingJens Hillengass, Maximilian Merz, Stefan Delorme
Journal of Cancer Research and Clinical Oncology|June 13, 2015
Meeting report of the 5th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myelomaMaximilian Merz, Jens Hillengass, Hartmut Goldschmidt
Deutsches Arzteblatt International|October 19, 2023
In ReplyFlorian Lordick, Maximilian Merz, Achim Aigner
Investigative Radiology|June 5, 2012
Quantitative contrast-enhanced ultrasound for imaging antiangiogenic treatment response in experimental osteolytic breast cancer bone metastasesMaximilian Merz, Dorde Komljenovic, Wolfhard Semmler, et al.
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Nature Cancer|August 26, 2024
A comeback for checkpoint inhibition in multiple myelomaMaximilian Merz
Blood|September 25, 2025
Losing CD38 in myelomaMaximilian Merz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2024
Reply to Z. Yin et alNico Gagelmann, Maximilian Merz
Clinical Lymphoma, Myeloma & Leukemia|September 1, 2020
Bone Diseases and Supportive CareJens Hillengass, Maximilian Merz
Blood|January 9, 2025
GSI: myeloma-cold case closed?Maximilian Merz, Nico Gagelmann
Seminars in Hematology|August 2, 2024
Fast and furious: Changing gears on the road to cure with chimeric antigen receptor T cells in multiple myelomaNico Gagelmann, Maximilian Merz
Seminars in Hematology|May 16, 2018
Minimal residual disease in multiple myeloma: use of magnetic resonance imagingJens Hillengass, Maximilian Merz, Stefan Delorme
Journal of Cancer Research and Clinical Oncology|June 13, 2015
Meeting report of the 5th Heidelberg Myeloma Workshop: current status and developments in diagnosis and therapy of multiple myelomaMaximilian Merz, Jens Hillengass, Hartmut Goldschmidt
Deutsches Arzteblatt International|October 19, 2023
In ReplyFlorian Lordick, Maximilian Merz, Achim Aigner
Investigative Radiology|June 5, 2012
Quantitative contrast-enhanced ultrasound for imaging antiangiogenic treatment response in experimental osteolytic breast cancer bone metastasesMaximilian Merz, Dorde Komljenovic, Wolfhard Semmler, et al.
Pageof 13